Yao-Chung Liu, M.D.

Education

PhD Stutent , PhD Stutent , Institude of Biochemistry and Molecular Biology, National Yang-Ming University

Chung Shan Medical University

Current Position

Attending physician, Division of Hematology , Department of Internal Medicine, Taipei Veterans Gernal Hosptial

Experiences

Resident Doctor, Internal Medicine, Taipei Veterans Gerneral Hospital

Resident Doctor, Division of Hematology, Taipei Veterans General Hospital

Resident Doctor, Division of Chemoradiotherapy, Department of Oncology, Taipei Veterans General Hospital

Lecturer, Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan

Research Fellow ,Brigham and Women's Hospital, Molecular Pathology & Oncology Lab, Boston, U.S.A.

License

Board of Internal Medicine

Board of Hematology

Board of Oncology

Board of Hematopoietic stem cell transplantation

Medical Expertise

Medical oncology, Hematology, Bone marrow transplantation

Language

Mandarin Taiwanese English

Publications

1. Liu YC, Kwon J, Fabiani E, Xiao Z, Liu YV, Follo MY, Liu J, Huang H, Gao C, Liu J, Falconi G, ValentiniL, Gurnari C, Finelli C, Cocco L, Liu JH, Jones AI, Yang J, Yang H, Thoms JAI, Unnikrishnan A, Pimanda JE, Pan R, Bassal MA, Voso MT*, Tenen DG*, Chai L*.Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy. N Engl J Med. 2022 May 26;386(21):1998-2010. (2021 Impact factor: 176.079)
2. Yang J, Gao C, Liu M, Liu YC, Kwon J, Qi J, Tian X, Stein A, Liu YV, Kong NR, Wu Y, Yin S, Xi J, Chen Z, Kumari K, Wong H, Luo H, Silberstein LE, Thoms JAI, Unnikrishnan A, Pimanda JE, Tenen DG*, Chai L*. Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy. Cancer Res. 2021 Dec 1;81(23):6018-6028.
3. Liu YC, Su CW, Ko PS, Lee RC, Liu CJ, Huang YH, Gau JP, Liu JH*. A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma. Asia Pac J ClinOncol. 2022 Feb;18(1):19-27.
4. Xu LH, Fang JP, Liu YC, Jones AI, Chai L*.Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia. Blood Cancer J. 2020 Jan 9;10(1):1.
5. Liu YC*, Wu CJ, Ko PS, Chien SH, Fan NW, Wang HY, Gau JP, Liu CJ, Hsiao LT, Chiou TJ, Liu CY, Liu JH.Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: A cohort study in a high endemic area. J MicrobiolImmunol Infect. 2020 Apr;53(2):274-282. (2021 Impact factor: 10.273)